Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,694.80 -6.13 -0.23%
FTSE 100 6,349.95 -24.26 -0.38%
DAX 8,234.30 +4.79 0.06%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Cubist Pharmaceuticals Inc

+ Add to Watchlist

CBST:US

51.1300 USD 1.1600 2.32%

As of 20:10:00 ET on 06/18/2013.

Snapshot for Cubist Pharmaceuticals Inc (CBST)

Open: 50.0200 Day's Range: 49.8200 - 51.1300 Volume: 762,394
Previous Close: 49.9700 52wk Range: 36.7300 - 56.6800 1-Yr Rtn: +26.59%

Stock Chart for CBST

No chart data available.
  • CBST:US 51.1100
  • 1D
  • 1M
  • 1Y
49.9700
Interactive CBST Chart

Previous Close

Key Statistics for CBST

Current P/E Ratio (ttm) 25.3119
Estimated P/E(12/2013) 27.7278
Relative P/E vs. SPX 1.5672
Earnings Per Share (USD) (ttm) 2.0200
Est. EPS (USD) (12/2013) 1.8440
Est. PEG Ratio 1.0665
Market Cap (M USD) 3,334.00
Shares Outstanding (M) 65.21
30 Day Average Volume 971,277
Price/Book (mrq) 3.2833
Price/Sale (ttm) 3.4775
Dividend Indicated Gross Yield -%
Cash Dividend -
Last Dividend
5 Year Dividend Growth -
Next Earnings Announcement 07/19/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CBST

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CBST

Cubist Pharmaceuticals, Inc. is a drug company that discovers, develops, and commercializes novel drugs to treat infections. The Company's lead product is a unique agent with bactericidal activity that addresses the critical need for new antibiotics with potent activity against life threatening infections.

Michael Weston Bonney "Mike"Chief Executive OfficerRobert J Perez "Rob"President/COO
Steven C Gilman "Steve"Exec VP:Research & DevelopmentMichael Tomsicek "Mike"Senior VP/CFO
More Company Profile & Key Executives for CBST

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil